Failure to take medication as prescribed significantly increases the risk that patients will experience complications resulting in injury or death, and propagate higher healthcare costs overall. The medical establishment’s approach to adherence i

Detailed information on the current drug pipeline. This report provides insight into the pipeline status of alcoholism drugs by company and by stage as well as a summary of the latest news and developments in this area.

The continued uptake of existing brands and the launch of two opioid antagonists will cause the market to grow at a compound annual growth rate of 13.5% from 2006 to reach $304m across the seven major markets by 2016. The alcohol dependence market requ

This report provides full analysis of the current and future Opioid market, with indication-specific sales forecasts to 2017 of marketed brands, generics, and key pipeline drugs in the US, 5EU, and Japan.

Detailed information on the current drug pipeline. This report provides insight into the pipeline status of poisoning drugs by company and by stage as well as a summary of the latest news and developments in this area.

Detailed information on the current drug pipeline. This report provides insight into the pipeline status of antidote drugs by company and by stage as well as a summary of the latest news and developments in this area.

Detailed information on the current drug pipeline. This report provides insight into the pipeline status of smoking cessation drugs by company and by stage as well as a summary of the latest news and developments in this area.

Opioid abuse is a growing medical challenge, yet few developments have been made in its treatment in recent years. The market requires clarification of the goals of therapy - to remove the addictive behavior or to just manage the addiction and modify t

This report comments on strategic and commercial issues that may affect current product positioning and discusses key compounds such as naltrexone reformulations, nicotine replacement therapies, and novel vaccine therapies that have the potential to cr